Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial von GULLESTAD, Lars, IVERSEN, Martin, GUDE, Einar, RUNDQVIST, Bengt, FAGERTUN, Hans E, SOLBU, Dag, BERGH, Claes-Håkan, MORTENSEN, Svend-Aage, EISKJAER, Hans, RIISE, Gerdt C, MARED, Lena, BJØRTUFT, Øystein, EKMEHAG, Björn, JANSSON, Kjell, SIMONSEN, Svein

Volltext

Cyclosporine C2 Levels Have Impact on Incidence of Rejection in De Novo Lung but Not Heart Transplant Recipients: The NOCTURNE Study von Iversen, Martin, MD, PhD, Nilsson, Folke, MD, PhD, Sipponen, Jorma, MD, Eiskjaer, Hans, MD, PhD, Mared, Lena, MD, Bergan, Stein, PhD, Nyström, Ulla, RN, Fagertun, Hans E., MSc, Solbu, Dag, MSc, Simonsen, Svein, MD, PhD

Volltext

Two-Year Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial von GULLESTAD, Lars, MORTENSEN, Svend-Aage, RUNDQVIST, Bengt, FAGERTUN, Hans E, SOLBU, Dag, IVERSEN, Martin, EISKJAER, Hans, RIISE, Gerdt C, MARED, Lena, BJØRTUFT, Øystein, EKMEHAG, Björn, JANSSON, Kjell, SIMONSEN, Svein, GUDE, Einar

Volltext

Effectiveness of nystatin in polysymptomatic patients. A randomized, double-blind trial with nystatin versus placebo in general practice von Santelmann, Heiko, Laerum, Even, Roennevig, Joergen, Fagertun, Hans E

Volltext

Determination of maintenance Jarlsberg® cheese dose to keep the obtained serum osteocalcin level; a response surface pathway designed de-escalation dose study with individual start... von Lundberg, Helge Einar, Holo, Helge, Holand, Trond, Fagertun, Hans E., Larsen, Stig

Volltext

Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance von Lindkær-Jensen, Steen, Larsen, Stig, Habib-Lindkær-Jensen, Nina, Fagertun, Hans E

Volltext

Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance von Lindkær-Jensen, Steen, Larsen, Stig, Lindkær-Jensen, Nina Habib, Fagertun, Hans E.

Volltext

Determination of maintenance Jarlsberg® cheese dose to keep the obtained serum osteocalcin level; a response surface pathway designed de-escalation dose study with individual start... von Lundberg, Helge Einar, Holo, Helge, Holand, Trond, Fagertun, Hans E, Larsen, Stig

Volltext bestellen

Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance von Lindkær-Jensen, Steen, Larsen, Stig, Lindkær-Jensen, Nina Habib, Fagertun, Hans E

Volltext bestellen

Ketoprofen controlled release (CR) in the treatment of osteoarthrosis; a double blind, randomized multicentre study of single morning versus evening dose von Vinje, Odd, Fagertun, Hans E., Laerum, Even, Lund, Henrik, Larsen, Stig

Volltext

Conjugated Linoleic Acid Reduces Body Fat Mass in Overweight and Obese Humans von Gudmundsen, Ola, Blankson, Henrietta, Stakkestad, Jacob A., Fagertun, Hans, Thom, Erling, Wadstein, Jan

Volltext

Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction von Grundt, Heidi, Nilsen, Dennis Winston T, Hetland, Øyvind, Valente, Edward, Fagertun, Hans Eirik

Volltext

Selection criteria for endoscopic retrograde cholangiopancreaticography (ERCP) in patients with gallstone disease von Trondsen, Frik, Edwin, Bjørn, Reiertsen, Ola, Fagertun, Hans, Rosseland, Arne R.

Volltext

Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers von Berven, G, Bye, A, Hals, O, Blankson, H, Fagertun, H, Thom, E, Wadstein, J, Gudmundsen, O

Volltext

Prediction of Common Bile Duct Stones Prior to Cholecystectomy: A Prospective Validation of a Discriminant Analysis Function von Trondsen, Erik, Edwin, Bjørn, Reiertsen, Ola, Færden, Arne E, Fagertun, Hans, Rosseland, Arne R

Volltext